AVANOS MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.7 USD | -0.05% |
|
-2.45% | -16.63% |
Financials (USD)
| Sales 2024 * | 691M | Sales 2025 * | 729M | Capitalization | 807M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.17 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.11 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 3,771 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.15% |
More Fundamentals
* Assessed data
More news
Latest transcript on Avanos Medical, Inc.
More recommendations
More press releases
| 1 day | -0.05% | ||
| 1 week | -2.45% | ||
| Current month | -6.08% | ||
| 1 month | -2.25% | ||
| 3 months | -2.40% | ||
| 6 months | +0.27% | ||
| Current year | -16.63% |
1 week
18.40
18.98
1 month
18.3920.13
Current year
17.3923.09
1 year
17.2431.31
3 years
17.2445.82
5 years
17.2453.61
10 years
17.2472.96
| Managers | Title | Age | Since |
|---|---|---|---|
Joseph Woody
CEO | Chief Executive Officer | 58 | 17-06-25 |
Michael Greiner
DFI | Director of Finance/CFO | 51 | 19-12-31 |
| Compliance Officer | - | 20-09-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gary Blackford
CHM | Chairman | 66 | 14-10-30 |
Patrick O'Leary
BRD | Director/Board Member | 66 | 14-10-30 |
John Byrnes
BRD | Director/Board Member | 65 | 14-09-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.42% | 27 M€ | -7.00% | - | |
| 0.19% | 45 M€ | -2.89% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 18.7 | -0.05% | 291,865 |
| 24-04-17 | 18.71 | +0.32% | 310,519 |
| 24-04-16 | 18.65 | -1.06% | 112,713 |
| 24-04-15 | 18.85 | +1.84% | 293,279 |
| 24-04-12 | 18.51 | -3.44% | 164,886 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotes
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Companyâs acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Calendar
2024-04-24
- Annual General Meeting
Related indices
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
18.7
USD
Average target price
23.5
USD
Spread / Average Target
+25.67%
| 1st Jan change | Capi. | |
|---|---|---|
| -16.63% | 808M | |
| -4.36% | 184B | |
| -3.87% | 105B | |
| -4.38% | 67.09B | |
| +8.23% | 51.61B | |
| +15.54% | 47.55B | |
| -0.82% | 39.95B | |
| +7.16% | 27.62B | |
| -12.48% | 25.74B | |
| -1.68% | 25.62B |
- Stock Market
- Equities
- AVNS Stock
